MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1058.38%
Quick Ratio
1058.38%
Cash Ratio
151.03%
Debt to Asset Ratio
29.50%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Less accumulated depreciation
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Deferred revenue, net of current
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
90,104
159,859
129,883
208,343
Marketable securities
531,000
506,361
247,221
182,915
Collaboration receivable
0
0
7,000
-
Other receivables
4,920
4,609
4,600
4,965
Prepaid expenses and other current assets
5,382
6,718
4,481
5,594
Total current assets
631,406
677,547
393,185
401,817
Total property and equipment, at cost
61,484
58,053
53,599
53,122
Less accumulated depreciation
31,552
29,644
27,613
25,524
Property and equipment, net
29,932
28,409
25,986
27,598
Operating lease right-of-use assets
24,056
24,693
24,386
25,065
Restricted cash
4,939
4,947
4,954
4,950
Other long-term assets
828
832
148
411
Total assets
691,161
736,428
448,659
459,841
Accounts payable
7,152
7,900
3,550
14,509
Accrued expenses and other current liabilities
25,773
25,594
26,694
17,902
Current deferred revenue
22,103
33,059
29,571
24,791
Current portion of operating lease liability
4,630
4,483
4,397
4,241
Total current liabilities
59,658
71,036
64,212
61,443
Deferred revenue, net of current
105,623
103,635
111,332
111,894
Defined benefit plan liability
5,242
5,260
5,265
4,740
Operating lease liability, net of current
33,357
34,581
34,794
35,927
Total liabilities
203,880
214,512
215,603
214,004
Common stock, 0.0001 par value 500,000,000 shares authorized, 85,226,427 and 65,543,723 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
9
8
7
6
Additional paid-in capital
1,057,551
1,048,371
714,090
680,157
Accumulated other comprehensive loss
-5,165
-4,746
-3,827
-3,247
Accumulated deficit
-565,114
-521,717
-477,214
-431,079
Total stockholders' equity
487,281
521,916
233,056
245,837
Total liabilities and stockholders' equity
691,161
736,428
448,659
459,841
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$531,000K (140.09%↑ Y/Y)Cash and cashequivalents$90,104K (29.78%↑ Y/Y)Prepaid expenses andother current assets$5,382K (-17.21%↓ Y/Y)Other receivables$4,920K (107.59%↑ Y/Y)Total property andequipment, at cost$61,484K (17.15%↑ Y/Y)Total current assets$631,406K (110.84%↑ Y/Y)Property and equipment,net$29,932K (3.03%↑ Y/Y)Operating leaseright-of-use assets$24,056K (-6.30%↓ Y/Y)Restricted cash$4,939K (-0.22%↓ Y/Y)Other long-termassets$828K (86.07%↑ Y/Y)Less accumulateddepreciation$31,552K (34.67%↑ Y/Y)Total assets$691,161K (92.21%↑ Y/Y)Total liabilities andstockholders' equity$691,161K (92.21%↑ Y/Y)Total stockholders'equity$487,281K (81.77%↑ Y/Y)Total liabilities$203,880K (122.81%↑ Y/Y)Accumulated deficit-$565,114K (-39.88%↓ Y/Y)Accumulated othercomprehensive loss-$5,165K (-53.13%↓ Y/Y)Additional paid-in capital$1,057,551K (56.57%↑ Y/Y)Deferred revenue, net ofcurrent$105,623K (1210.62%↑ Y/Y)Total currentliabilities$59,658K (42.55%↑ Y/Y)Operating leaseliability, net of current$33,357K (-9.94%↓ Y/Y)Defined benefit planliability$5,242K (15.01%↑ Y/Y)Common stock, 0.0001par value...$9K (50.00%↑ Y/Y)Accrued expenses andother current...$25,773K (87.21%↑ Y/Y)Current deferredrevenue$22,103K (20.06%↑ Y/Y)Accounts payable$7,152K (28.15%↑ Y/Y)Current portion ofoperating lease liability$4,630K (13.09%↑ Y/Y)

Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics, Inc. (GLUE)